Mahamaya Lifesciences LimitedBSE: MAHALIFE

Announcement under Regulation 30 (LODR)-Change in Management

· Issued by Mahamaya Lifesciences Limited via BSE India

Filed with BSE · · 3 pages · English

Summary by 6ix AI

This filing is a disclosure regarding changes in management at Mahamaya Lifesciences Limited, as required by SEBI regulations. The company has announced the appointment and reappointment of several directors, including Dr. Bhagirath Choudhary as an Independent Director and the re-designation of Mr. Krishnamurthy Ganesan as Chairman. Additionally, Mr. Prashant Krishnamurthy has been appointed as the new Managing Director.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/announcement-under-regulation-30-lodr-change-in-management-39

The details as per SEBI Circular no. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026 with respect to the aforesaid matters are annexed hereto. The above information will also be made available on the website of the Company and can be accessed at www.mahamayalifesciences.com Kush Mishra Kush Mishra

Mahamaya Lifesciences Limited on 6ix

Earlier from Mahamaya Lifesciences

Later from Mahamaya Lifesciences

All Mahamaya Lifesciences news releases